Carroll Financial Associates’s Maxim Integrated Products MXIM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-301
Closed -$31K 2022
2021
Q2
$31K Buy
301
+14
+5% +$1.37K ﹤0.01% 960
2021
Q1
$26K Sell
287
-825
-74% -$75.7K ﹤0.01% 949
2020
Q4
$98K Hold
1,112
0.01% 521
2020
Q3
$75K Hold
1,112
0.01% 548
2020
Q2
$67K Hold
1,112
0.01% 580
2020
Q1
$54K Hold
1,112
0.01% 558
2019
Q4
$68K Hold
1,112
0.01% 586
2019
Q3
$64K Buy
1,112
+741
+200% +$42.9K 0.01% 589
2019
Q2
$22K Hold
371
﹤0.01% 807
2019
Q1
$19K Hold
371
﹤0.01% 777
2018
Q4
$18K Sell
371
-42
-10% -$2.19K ﹤0.01% 707
2018
Q3
$23K Buy
413
+42
+11% +$2.53K ﹤0.01% 672
2018
Q2
$21K Hold
371
﹤0.01% 670
2018
Q1
$22K Sell
371
-46
-11% -$2.73K ﹤0.01% 653
2017
Q4
$21K Buy
417
+130
+45% +$6.75K ﹤0.01% 652
2017
Q3
$13K Hold
287
﹤0.01% 764
2017
Q2
$12K Buy
+287
New +$13.2K ﹤0.01% 804
2014
Q3
Sell
-180
Closed -$6K 972
2014
Q2
$6K Hold
180
﹤0.01% 689
2014
Q1
$6K Hold
180
﹤0.01% 632
2013
Q4
$5K Buy
+180
New +$5.21K ﹤0.01% 610

Other funds holding MXIM

Carroll Financial Associates's MXIM Position: Q3 2021 in Review

Carroll Financial Associates sold out of Maxim Integrated Products (MXIM) in Q3 2021, closing a stake of 301 shares — an estimated $31K sold.

Carroll Financial Associates first reported a position in MXIM in Q4 2013 and held it in 20 quarters. The position peaked at $98K in Q4 2020. 3 funds tracked by Wall St. Rank hold MXIM as of Q3 2021.

  • Carroll Financial Associates reported no remaining Maxim Integrated Products position as of Q3 2021 after selling out during the quarter.
  • Carroll Financial Associates sold 301 Maxim Integrated Products shares in Q3 2021, an estimated $31K.
  • Carroll Financial Associates first reported a position in Maxim Integrated Products in Q4 2013 and held it in 20 quarters.
  • Carroll Financial Associates's Maxim Integrated Products position peaked at $98K in Q4 2020.
  • 3 funds tracked by Wall St. Rank held Maxim Integrated Products as of Q3 2021.

Based on Carroll Financial Associates's 13F filing for Q3 2021, filed 7 Oct 2021.